<SEC-DOCUMENT>0001213900-22-016845.txt : 20220610
<SEC-HEADER>0001213900-22-016845.hdr.sgml : 20220610
<ACCEPTANCE-DATETIME>20220331163655
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001213900-22-016845
CONFORMED SUBMISSION TYPE:	DRSLTR
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20220331

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACTELIS NETWORKS INC
		CENTRAL INDEX KEY:			0001141284
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMUNICATIONS EQUIPMENT, NEC [3669]
		IRS NUMBER:				522160309
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DRSLTR

	BUSINESS ADDRESS:	
		STREET 1:		47800 WESTINGHOUSE DR
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94539
		BUSINESS PHONE:		510-545-1040

	MAIL ADDRESS:	
		STREET 1:		47800 WESTINGHOUSE DR
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94539
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRSLTR
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 23%"><IMG SRC="image_001.jpg" ALT="" STYLE="width: 28px; height: 30px"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 77%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>mwe.com</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eyal
    Peled</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attorney
    at Law</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">epeled@mwe.com</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">+1
    212 547 5477</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
31, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S.
Securities and Exchange Commission</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Division
of Corporation Finance</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office
of Technology<BR>
100 F Street, N.E.<BR>
Washington, D.C. 20549</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 72px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mindy Hooker</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Martin
James</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jennifer
Angelini</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jay
Ingram</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Actelis Networks, Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Draft
Registration Statement on Form S-1</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Submitted
February 10, 2022</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CIK
No. 0001899005</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dear
Mr. Angelini:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
behalf of Actelis Networks, Inc. (the &ldquo;Company&rdquo;), we are writing to submit the Company&rsquo;s responses to the comments
of the staff (the &ldquo;Staff&rdquo;) of the Division of Corporation Finance of the Securities and Exchange Commission (the &ldquo;Commission&rdquo;)
dated March 8, 2022, relating to the above referenced Draft Registration Statement on Form S-1 (CIK No. 0001899005) submitted by the
Company on February 10, 2022 (the &ldquo;Draft Registration Statement&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concurrent
with the submission of this letter, the Company is filing via EDGAR Amendment No. 1 to the Draft Registration Statement (&ldquo;Amendment
No. 1&rdquo;), which reflects the Company&rsquo;s responses to the comments received by the Staff and certain updated information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
ease of review, we have set forth below each of the numbered comments of your letter and the Company&rsquo;s responses thereto. Capitalized
terms used herein but not defined herein have the meanings given to such terms in Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Draft
Registration Statement on Form S-1</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Prospectus
Summary, page 1</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
    balance your disclosure in the summary with information regarding your history of operating losses, negative cash flows, and significant
    indebtedness. Additionally, please highlight that your auditor has expressed substantial doubt about your ability to continue as
    a going concern.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company has revised its disclosure on page  2 of Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%"><IMG SRC="image_002.jpg" ALT=""></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>One
    Vanderbilt Avenue New York NY 10017-3852 Tel +1 212 547 5400 Fax +1 212 547 5444</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>US
    practice conducted through McDermott Will &amp; Emery LLP.</I></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Risk
Factors, page 11</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
note that you utilize turn-key and OEM contract manufacturers in Israel and Taiwan. Please add a risk factor assessing the material risks
associated with your manufacturing arrangements, including without limitation the risk of shipping delays.</B></FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company has revised its risk factor on pages 14 and 15 of Amendment No.&nbsp;1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Actelis
Israel received Israeli government grants . . . , page 22</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
    revise your disclosure regarding the disagreement between Actelis Israel and the IIA to (i) describe the process and timing to resolve
    this disagreement, (ii) quantify the royalties at issue, and (iii) describe the potential consequences and assess the material risks
    to the company and investors if you do not prevail.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company respectfully notes that it decided to align with the position taken by the IIA.
Accordingly, the Company has revised its risk factor on page 24 of Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Our
Bylaws designate a state or federal court located within the State of Delaware as the exclusive forum . . . , page 30</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
    exclusive forum provisions described in this and the following risk factor appear to be inconsistent. Please revise for consistency,
    and ensure that your by-laws and charter that will be in effect following the offering conform to these provisions.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company has revised its disclosure on pages 32 and 85 of Amendment
No.&nbsp;1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cautionary
Note Regarding Forward-Looking Statements, page 32</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
    note your references to forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Please
    be advised that the safe harbor for forward-looking statements is inapplicable in this context, because you are not currently a reporting
    company. See Section 27A(a)(1) of the Securities Act. Therefore, please either delete all references to the Private Securities Litigation
    Reform Act or make it clear that the safe harbor does not apply to this offering.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company has revised its disclosure on pages 35 and  42 of Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Use
of Proceeds, page 34</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
    disclose the amount of any debt you intend to repay with proceeds from the offering. Refer to Instruction 4 to Item 504 of Regulation
    S-K. If you do not intend to repay any debt, please revise the disclosure in your Liquidity and Capital Resources section on page
    43 to address how you intend to meet your cash needs, including debt obligations, over the next 12 months when you do not plan to
    use any proceeds from the offering to meet these obligations.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company respectfully notes that it does not intend to repay any debt with proceeds from
the offering. The Company has revised its disclosure on pages 46 and 48 of Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: left; width: 34%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><IMG SRC="image_002.jpg" ALT=""></TD><TD STYLE="vertical-align: bottom; width: 33%; padding-right: 0pt; padding-left: 0pt; text-align: center; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Capitalization,
page 36</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
    include bold double lines under the cash and cash equivalent amounts to clearly distinguish them from your capitalization.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company has revised its disclosure on page 38 of Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Management&rsquo;s
Discussion and Analysis of Financial Condition</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Liquidity
and Capital Resources</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Convertible
Notes, Loans, and Warrant, page 43</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
    note your disclosure that &ldquo;upon consummation of an equity financing in us, the lenders have the rights to convert the principal
    amount of the loan in consideration for such number of our securities of the most favorable class and on the most favorable terms
    as issued under the equity financing, at a conversion price per share reflecting a discount of 30% plus an additional 1% for each
    two calendar months following March 2017.&rdquo; Please revise to (i) clarify whether these rights are triggered by the offering,
    (ii) disclose the number of shares subject to these rights, and (iii) disclose the conversion price in relation to the initial public
    offering price. Additionally, please revise your disclosure on page 9 to specifically address the treatment of these shares throughout
    the prospectus.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company has revised its disclosure on pages 10 and 47 of Amendment
No.&nbsp;1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
    revise your disclosure regarding the Migdalor loan to identify the number of shares the counterparty has the option to acquire (making
    needed assumptions) and to disclose the purchase price therefor in relation to the initial public offering price. Revise the following
    sentence for clarity, as it implies that the option will automatically convert into shares, potentially without payment: &ldquo;Upon
    consummation of the offering, the option may convert into shares of common stock at a formula to be calculated on the initial offering
    price.&rdquo; Additionally, please file the Migdalor loan agreement as an exhibit to your registration statement.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company will supplementally attach the Migdalor loan agreement as an exhibit to Amendment
No. 1. In addition, the Company has revised its disclosure on page 43 and 48 of Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
    describe the material terms of your convertible notes, including the provisions governing optional and mandatory conversions. Identify
    the number of shares for which your outstanding notes may be converted, and clarify whether the conversion price is a 40% discount
    to the initial public offering price. Additionally, disclose the number of shares the underwriter may purchase pursuant to the warrant
    issued in connection with your private placement of convertible notes, as well as the exercise price thereof, and specifically address
    the treatment of this warrant and underlying shares on page 9.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company has revised its disclosure on pages 10 and 48 of Amendment No. 1. The Company will
supplementally provide the number of shares the underwriter may purchase pursuant to the warrant issued in connection with the private
placement of the Company&rsquo;s convertible notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Our
Business, page 49</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; font-size: 10pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-right: 0pt; text-align: justify; font-size: 10pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please revise your disclosure to include a specific, clear description of your current operations, status of product and service development, and markets and distribution methods. Distinguish clearly your aspirations from your accomplishments. Address, without limitation, the following areas:</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; font-size: 10pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-right: 0pt; text-align: justify; font-size: 10pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; font-size: 10pt; padding-left: 0pt; text-indent: 0pt; width: 0.5in">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt; font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt; font-size: 10pt">Describe the state of development
with respect to your 5G, MMwave, and computing capabilities technology, including material hurdles to overcome.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: left; width: 34%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><IMG SRC="image_002.jpg" ALT=""></TD><TD STYLE="vertical-align: bottom; width: 33%; padding-right: 0pt; padding-left: 0pt; text-align: center; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; width: 0.5in; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="width: 0.25in; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expand your description
of EMS software, including whether this is propriety, still under development, customized to customer specifications, and other relevant
information.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">Describe the contractual terms for the services and software
you offer, indicating whether these are bundled with your products or sold separately, on an one-time or on-going basis.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">Describe the warranty you provide or offer in relation to your
products.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">Revise statements regarding your intent to address IoT verticals
globally, to clearly identify and distinguish your current markets and future market plans.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">Identify the locations of your &ldquo;many distributors and partners
around the world,&rdquo; and describe these relationships.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT></TD>
    <TD STYLE="text-align: justify; padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">Describe your sales teams and clarify where they operate, avoiding
references to regions where you lack presence.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT></TD>
    <TD STYLE="padding-right: 0pt; padding-left: 0pt; text-indent: 0pt">Identify the basis for your claim to be &ldquo;best in class.&rdquo;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company has revised its disclosure on pages 55-65 of Amendment No. 1, and with respect
to point 8 of this comment, the Company has deleted the reference to &ldquo;best in class&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
    revise your disclosure to describe the need for any governmental approval of your principal products and services, and the effect
    of existing or probable governmental regulations on your business. See Items 101(h)(viii) and (ix) of Regulation S-K. With respect
    to the statement that your &ldquo;products are already approved to deliver sensitive information for many critical IoT applications,&rdquo;
    identify this approval and the extent of its application. Revise your description of the Bipartisan Infrastructure Law to explain
    its relevance to your business.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company has revised its disclosure on pages 20 and 66 of Amendment No. 1. In addition,
in response to the Staff&rsquo;s comment regarding the relevance of the Bipartisan Infrastructure Law to the Company&rsquo;s
business, the Company has revised its disclosure on page 65 of Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 93%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
    disclose the duration of your patents. See Item 101(h)(vii) of Regulation S-K.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company has revised its disclosure on page 67 of Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Principal
Stockholders, page 75</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
    text preceding the table of beneficial ownership and notes thereto describe the treatment of options for purposes of calculating
    beneficial ownership, yet the table refers to shares on an as-converted basis and includes a column for voting percentage. Please
    revise your disclosure to (i) clarify whether &ldquo;as-converted&rdquo; refers to the exercise of the options described in the table
    notes, or to some other basis, and (ii) explain why ownership and voting percentages might differ.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company has revised its disclosure on page 81 of Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: left; width: 34%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><IMG SRC="image_002.jpg" ALT=""></TD><TD STYLE="vertical-align: bottom; width: 33%; padding-right: 0pt; padding-left: 0pt; text-align: center; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Description
of Securities, page 77</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
    introductory text to this section refers to a corporate conversion. Please revise your disclosure to describe this corporate conversion
    or to eliminate the reference. Please also reconcile apparently inconsistent references to your charter and articles of incorporation.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company has revised its disclosure on page 83 of Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
    note that non-voting common stock and Series A and B convertible preferred stock were outstanding as of December 30, 2020 (page F-4).
    Please revise the description of the voting rights of your common stock to reflect the non-voting common stock. Clarify whether all
    outstanding preferred stock will automatically convert into common stock in connection with the offering, as disclosure on page 9
    appears to suggest. If any preferred stock will remain outstanding, please further revise your disclosure to describe the voting,
    conversion, and other rights. Refer to Item 202(a)(4) of Regulation S-K. Please also confirm the stated number of authorized stock
    of each class.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company has revised its disclosure on page 83 of Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
    set forth the approximate number of holders of each class of your common equity as of the latest practicable date. Refer to Item
    201(b)(1) of Regulation S-K.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company has revised its disclosure on page 83 of Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
    disclose the percentage of your outstanding shares that are entitled to registration rights under the Amended and Restated Stockholder
    Rights Agreement, dated as of February 2, 2016. Please also file this agreement as an exhibit to your registration agreement.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company will supplementally provide the disclosure requested on page 87 of Amendment
No. 1. In addition, the Company filed this agreement as an exhibit to Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Legal
Matters, page 94</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
    note your disclosure that two firms will pass upon the validity of the shares being offered, but your exhibit index lists the legal
    opinion of only one firm. Please revise to reconcile this apparent inconsistency. Refer to Item 601(b)(5) of Regulation S-K.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company has revised its disclosure on page 100  of Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Consolidated
Statements of Comprehensive Loss, page F-5</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
    revise this statement and other sections of the filing, as applicable, to present your loss per share amounts rounded to the nearest
    cent (i.e., using only two decimal points), in order not to imply a greater degree of precision than exists.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company has revised its disclosure on page F-5 of Amendment No. 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: left; width: 34%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><IMG SRC="image_002.jpg" ALT=""></TD><TD STYLE="vertical-align: bottom; width: 33%; padding-right: 0pt; padding-left: 0pt; text-align: center; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>k.
Revenue recognition, page F-10</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
    describe to us in detail the arrangements under which you provide certain customers with software updates that you choose to develop
    and enhancements related to your management software. Clearly describe to us your accounting for the revenue related to these arrangements,
    including when you recognize revenue&mdash;&ldquo;over- time&rdquo; or at a &ldquo;point in time,&rdquo; the related time periods and
    the authoritative guidance on which you are relying. Revise this note to provide clear disclosure of that policy.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
The Company respectfully advises the Staff that the Company offers EMS management software (either on a perpetual or on a term-based
basis, usually for 12 months and sometimes for 36 months) to its customers and software support service which allows them to receive
some additional features or free upgrades (i.e., unspecified software updates).&nbsp; The Company provides to certain customers
software updates that it chooses to develop, which the Company refers to as unspecified software updates and enhancements related to
the Company&rsquo;s management software through support service contracts. The Company also offers its customers product support
services which include telephone support, remote diagnostics and access to on-site technical support personnel. Such software
support services are mostly sold together with the EMS Management Software, and could be sold later after the software has been
sold, typically for periods of up to 12 months. It should be noted that the EMS management software arrangements may be sold without
software support services, as such an inclusion is at customer&rsquo;s discretion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
recording revenue, the Company follows the five steps model described under ASC 606 Revenue from contracts with customers (&ldquo;ASC
606&rdquo;). Specifically, when applying ASC 606 to the software support services, the Company concluded on its accounting based on the
following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Identify
the contract with a customer (step 1)</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has concluded that a contract with a customer which includes an engagement of the software services, is identified, based on
the provisions of ASC 606-10-25-1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s customers sign a contract before receiving any goods or services from the Company. The contract establishes the rights
and obligations of each party to the contract. The payment terms are specified in the contract (typically net-30/net-60). The Company
assesses collectability based on customer&rsquo;s ability and intent and considers, among other things, collection history with similar
customers. Contracts with US customers are typically paid upfront, and other contracts are typically paid on a quarterly basis. The Company
has a standard agreement and/or sales order confirmation constituting an agreement between the parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Identifying
the performance obligation in the contract (step 2):</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described above, the software support services can either be sold with the EMS management software (as part of the initial engagement)
or at a later stage (such as when an EMS management software customer decides to subscribe for such software support services subsequent
to the initial engagement). The latter case involves a new engagement with the customer and is priced separately.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company concluded that such software support services are considered a separate performance obligation based on the provisions of ASC
606-10-25-14 and 25-19, mainly since the EMS management software can and is, sold without the services as it is functional on its own.
Additionally, these services are distinct within the context of the contract as they are, in some cases, negotiated separately from the
EMS management software agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Determine
the transaction price (step 3)</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transaction price consists of a fixed price only, as established in the contract. The Company typically receives payments from customers
upfront upon signing the contract. Since the Company&rsquo;s service contracts are typically for periods of up to 12 months, the Company
applies the practical expedient prescribed under ASC 606-10-32-18 which allows the Company not to adjust the transaction price for effects
of a significant financing component.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Allocate
the transaction price to the performance obligations in the contract (step 4)</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on the provisions of ASC 606-10-32-31 through to 32-33 the Company has established the software support services&rsquo; stand-alone selling
price, based on its best estimates, in an amount that depicts the amount of consideration to which the entity expects to be entitled
in exchange for transferring the promised goods or services to the customer. Accordingly, when the Company engages with a customer in
a contract to sell both the EMS management software and the services, the Company allocates the transaction price based on a relative
fair value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: left; width: 34%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><IMG SRC="image_002.jpg" ALT=""></TD><TD STYLE="vertical-align: bottom; width: 33%; padding-right: 0pt; padding-left: 0pt; text-align: center; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Recognize
revenue when (or as) the entity satisfies a performance obligation (step 5)</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
software support services are stand-ready obligation that are provided throughout the service period and therefore, the customer consumes
and receives benefit by the Company as it performs. Accordingly, and in-line with the provisions under ASC 606-10-25-27, these services
will be recognized ratably over time during the service period and the Software licenses, either perpetual or term-based will be recognized
at a point in time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
is aligned with <FONT STYLE="font-weight: normal">the description under ASC 606-10-25-18e which describes a stand ready obligation as
an example of a promised service. </FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Further,
ASC 606-10-55-184 through to ASC 606-10-55-186 provide an example of a stand ready obligation and explains that: &ldquo;<I>&hellip; the
entity concludes that the best measure of progress toward complete satisfaction of the performance obligation over time is a time-based
measure, and it recognizes revenue on a straight-line basis&hellip;</I>&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
response to the Staff&rsquo;s comment, the Company has revised its disclosure on page F-12 of Amendment No. 1 to <FONT STYLE="font-weight: normal">add
that all support services are recognized over-time</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>z.
Share-based compensation, page F-15</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
    provide us an analysis of equity issuances which occurred during the last twelve months that presents the grant dates of the issuances,
    as well as the underlying fair value of your common shares at each grant date. To the extent there were any significant fluctuations
    in the fair values from period-to-period, please describe to us the factors that contributed to these fluctuations. For equity transactions
    in which you estimated the fair value, please explain the significant factors, assumptions, and methodologies you used to determine
    fair value. Additionally, provide us the estimated offering price or range when it is available and explain to us the reasons for
    significant differences between recent valuations of your common shares leading up to the IPO and the estimated offering price.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fair
Value Determinations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Given
the absence of an active market for the Company&rsquo;s Common Shares (the &ldquo;Common Shares&rdquo;<I>)</I>, the Company&rsquo;s Board
of Directors (the &ldquo;Board&rdquo;) was required to estimate the fair value of the Common Shares at the time of each share-based compensation
award granted by the Company based upon several factors, including the Board&rsquo;s consideration of input from management and third-party
valuations (which third-party gave the Company consent to use for this purpose).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company further advises the Staff that
the Board has considered a variety of factors in determining the fair value of the Common Shares for purposes of granting and
measuring share-based compensation awards to date. In valuing the Common Shares, the Board determined the enterprise value of the
Company using valuation methods it deemed appropriate under the circumstances applicable at the valuation date including methods,
such as the income-based approach. The income-based approach used by the Company utilized the discounted cash flow method
(&ldquo;DCF&rdquo;) which estimates the enterprise value of the Company based on the estimated future cash flows that the Company
will generate. These future cash flows are discounted to their present values using an appropriate discount rate to reflect the
risks inherent in the Company achieving these estimated cash flows.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
an enterprise value was determined, the Company used either the option pricing method (&ldquo;OPM&rdquo;) or a combination of OPM
and the probability weighted expected return method (&ldquo;PWERM&rdquo;) to allocate such value to its Common Shares (the
&ldquo;Hybrid Method&rdquo;). The OPM treats common and preferred shares as call options on a business, with exercise prices based
on the liquidation preferences, participation rights and exercise prices of the equity instruments. The Common Shares only have
value if the funds available for distribution to the holders of Common Shares exceed the value of the liquidation preference of the
preferred stock at the time of a liquidity event, such as a merger, sale, or an initial public offering (&ldquo;IPO&rdquo;),
assuming the business has funds available to make a liquidation preference meaningful and collectible by shareholders. The Common
Shares are modeled as call options with a claim on the business at an exercise price equal to the remaining value immediately after
any preferred shares are liquidated. The OPM typically uses the Black-Scholes option pricing model to price the call option. Due to
the distribution structure of the different types of the Company&rsquo;s shares that requires distribution assumptions on multiple
input parameters the Monte Carlo simulation was used to price the call option. The estimated per share value of the Common Shares
derived from the OPM may then be discounted by a&nbsp;non-marketability&nbsp;factor due to the fact that stockholders of private
companies do not have access to trading markets similar to those enjoyed by stockholders of public companies, which impacts
liquidity. The discount for a lack of marketability (&ldquo;DLOM&rdquo;)&nbsp;is determined using the Finnerty model that estimates
a DLOM of securities by using an option pricing theory.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: left; width: 34%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><IMG SRC="image_002.jpg" ALT=""></TD><TD STYLE="vertical-align: bottom; width: 33%; padding-right: 0pt; padding-left: 0pt; text-align: center; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
PWERM, the value of a company&rsquo;s common shares is estimated based upon an analysis of future values for the entire enterprise assuming
various outcomes. For each of the various scenarios, an enterprise value is estimated and the rights and preferences for each shareholder
class are considered to allocate the enterprise value to Common shares. The common share value is then multiplied by a discount factor
reflecting the calculated discount rate and the timing of the event. The resulting value of the Common shares is then multiplied by an
estimated probability for each scenario. The probability and timing of each scenario are based on discussions between the Board and management.
Once the estimated per share value of the Common shares derived from the PWERM is calculated, a DLOM may then be applied to account for
a lack of access to an active public market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Hybrid Method estimates the PWERM across multiple scenarios in combination with the OPM to allocate the estimated equity value within
one or more of the scenarios. The Hybrid Method is appropriate for a company expecting a near term liquidity event, but where, due to
market or other factors, the likelihood of completing the liquidity event is uncertain. The Hybrid Method considers a company&rsquo;s
going concern nature, stage of development and the company&rsquo;s ability to forecast near and long-term future liquidity scenarios.
In the Company&rsquo;s hybrid method, besides staying private scenario treated by OPM model as described above, several IPO scenarios
were considered. The enterprise value was determined for scenarios using various approaches. Once the equity value was determined for
each scenario, the Company used the OPM to allocate value in the stay private scenario and the PWERM to allocate value in the IPO scenario(s),
before applying a DLOM. The relative probabilities between the future exit scenarios were determined by management based on the information
known to it at the time of the grant and an analysis of performance and market conditions at the time, including then current IPO valuations
of similarly situated companies and expectations as to the timing and likely prospects of future event scenarios.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2021, the fair value of the Common Share was estimated at $0.0466 by utilizing the Hybrid Method that incorporated two
scenarios: 1) IPO scenario and 2) remain private scenario. The weighted probability given to the IPO and a remain private scenario was
37.5% and 62.5%, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the IPO scenario, the IPO&rsquo;s share price was estimated based on discussions between the Company and the underwriters, resulting
in an estimated value range per Common Share. A DLOM of 8% was applied. Under the remain private scenario, the DCF method was applied
to estimate the equity value of the Company and the OPM model to allocate the resulting equity value to the various classes of securities
of the Company, resulting in a value of $0.0334 per common share, prior to a discount for the lack of marketability. A DLOM of 28% was
applied, resulting in a per Common Share value of approximately $0.0239.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
summary of the Company&rsquo;s stock option grants and the estimated fair values used to calculate stock-based compensation charges for
the period starting February 2021 through the date of this letter are set forth below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Date of Grant</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<BR> Shares<BR> Subject to<BR> Awards<BR> Granted</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise<BR> Price Per<BR> Share<SUP>(1)(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Deemed&nbsp;Fair<BR> Value Per<BR> Common<BR> Share for<BR> Financial<BR> Reporting</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-indent: -12pt; padding-left: 12pt">May 27, 2021</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,990,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">0.0296</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">0.0296</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israeli Laws including tax
    laws do not prohibit, sanction or fine options granted to employees with an exercise price below fair value; for accounting purposes,
    the compensation charge is taken by the Company for the full fair value per option of such grants.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The awards were approved by
    the Company board of directors</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="text-align: left; width: 34%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><IMG SRC="image_002.jpg" ALT=""></TD><TD STYLE="vertical-align: bottom; width: 33%; padding-right: 0pt; padding-left: 0pt; text-align: center; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR></TABLE><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>May
27,2021 Grant</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes that it is important to elaborate upon how it determined the fair value of the Common Shares underlying the grant. The
Company&rsquo;s Board, with input from management, determined the fair value of the Common Shares underlying these awards to be $0.0296
per share, based on a valuation report from an independent third-party valuation firm as of December&nbsp;31, 2020 (the &ldquo;December
2020 Valuation&rdquo;)&nbsp;using the DCF method.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board determined that as of the grant date, no material changes had occurred in the assumptions used by the independent third-party valuation
firm in the December 2020 Valuation. Accordingly, the Company believes that the $0.0296 per Common Share was an appropriate fair value
established by the Board for the May 27, 2021 Grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this letter, the Company does not know the estimated offering price or range. Therefore, the Company will supplementally
explain the reasons for significant differences between recent valuations to the IPO midpoint price once it becomes aware of the estimated
preliminary price range of its IPO offering price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>General</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 48px"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
    supplementally provide us with copies of all written communications, as defined in Rule 405 under the Securities Act, that you, or
    anyone authorized to do so on your behalf, present to potential investors in reliance on Section 5(d) of the Securities Act, whether
    or not they retain copies of the communications. Please contact the staff member associated with the review of this filing to discuss
    how to submit such copies.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Response</U>:
In response to the Staff&rsquo;s comment, the Company respectfully advises the Staff that it did not undertake any written communications,
as defined in Rule 405 under the Securities Act, to potential investors in reliance on Section 5(d) of the Securities Act. Should the
Company undertake any such written communication following the submission of this letter, the Company will supplementally provide the
Staff with a copy of any such written communications made to potential investors in reliance on Section 5(d) of the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Eyal Peled</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">cc:
Tuvia Barlev, Chief Executive Officer</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 34%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt"><IMG SRC="image_002.jpg" ALT=""></TD>
    <TD STYLE="vertical-align: bottom; width: 33%; padding-right: 0pt; padding-left: 0pt; text-align: center; font-size: 10pt">9</TD>
    <TD STYLE="width: 33%; padding-right: 0pt; padding-left: 0pt; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !I &H# 2(  A$! Q$!_\0
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M>1A@K@'@GYF &>FX'ISQG'KQ2_ULQ,KJIEU&<+ZQY=+?]ON46[=TGO;=&O\
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MP&-MXVB& ,=,8K^HKX4?#-?!7PM^&O@W;_R*7@#P=X9^Z3_R ?#NG:5U[_\
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9$(0BHI)*,(1A"*2222BDDK)(****19__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  N (8# 2(  A$! Q$!_\0
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M_ FJBV;5WA\8:/K""6VE5'\V.5)I?#KKYHCDD2)E3\<_V!_A/\,]$_X+K_\
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MOAUKG[0&H:[\%;/5U;^T;'X6R?&KX3(A1R-C>'O^$DBU_>JY=1_PD9<*'0L
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M\U7PY;KKNJ_$E=?TA]>T+3/ VC6Y\S7Y;KP_OE0(5 16,C0RML?X_P#V9O\
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;3.(M*\.Z/#IMH",\,T,*.XR1O+$8& "@#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
